C. O. Truxton

FDA Regulatory Profile

C. O. Truxton appears in FDA public data with 7 recalls — including 2 Class I (most serious) —, 0 510(k) clearances, 2 FDA inspections, and 1 compliance action on record. Its most recent recall (D-1116-2017, Class II) was initiated on April 20, 2017.

Summary

Total Recalls
7 (2 Class I)
510(k) Clearances
0
Inspections
2
Compliance Actions
1

Recent Recalls

NumberClassProductDate
D-1116-2017Class IIPhenobarbital Tablets USP, 15 mg, 1000 count bottles, Rx Only, Manufactured by West-ward PharmaceutiApril 20, 2017
D-1111-2017Class IPhenobarbital Tablets USP, 15 mg, 1000 count bottles, Rx Only, Manufactured by West-ward PharmaceutiApril 20, 2017
D-1114-2017Class IIPhenobarbital Tablets USP, 100 mg, a) 100 count bottles (NDC 0463-6152-01), b) 1000 count bottles (NApril 20, 2017
D-1112-2017Class IPhenobarbital Tablets USP, 30 mg, 1000 count bottles, Rx Only, Manufactured by West-ward PharmaceutiApril 20, 2017
D-1113-2017Class IIPhenobarbital Tablets USP, 60 mg, 1000 count bottles, Rx Only, Manufactured by West-ward PharmaceutiApril 20, 2017
D-1115-2017Class IIAmitriptyline HCL Tablets, USP 50 mg, 100 count bottles, Rx Only, Manufactured for: Qualitest PharmApril 20, 2017
D-0164-2016Class IIDoxycycline Hyclate Tablets, USP, 100 mg, 500-count bottle, Rx only, Distributed by: Truxton Inc. BeAugust 24, 2015